Psychosomatics
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Psychosomatics 49:168-175, April 2008
doi: 10.1176/appi.psy.49.2.168
© 2008 Academy of Psychosomatic Medicine
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Google Scholar
* Articles by Oesterheld, J. R.
* Articles by Sandson, N. B.
PubMed
* PubMed Citation
* Articles by Oesterheld, J. R.
* Articles by Sandson, N. B.
Related Collections
* Gender
* Primary Care
* Miscellaneous Somatic Therapies

Oral Contraceptives

Jessica R. Oesterheld, M.D., Kelly Cozza, M.D., and Neil B. Sandson, M.D.

Nearly 50 years ago, the introduction of Enovid© (norethynodrel 10 µg and mestranol 150 µg), which provided convenient and reliable contraception, revolutionized birth control. Reports of interactions between oral contraceptives (OCs) and other drugs began to trickle into the literature. At first, these drug interactions appeared to be random and unrelated. Increased understanding of P450 enzymes and phase II reactions of sulfation and glucuronidation has permitted preliminary categorization and assessment of the clinical relevance of these drug interactions.







Get information about faster international access.

Privacy Policy

Copyright © 2008 Academy of Psychosomatic Medicine. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. Academy of Psychosomatic Medicine
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org